Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Kappos

Showing results (91-100 of 225) with videos related to

Pageof 23
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 17, 2013
Temporal profile of lymphocyte counts and relationship with infections with fingolimod therapyG Francis, L Kappos, P O'Connor, et al.
Neurology|November 1, 1990
Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individualsM Pette, K Fujita, B Kitze, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 6, 2011
Oral fingolimod (FTY720) in relapsing multiple sclerosis: impact on health-related quality of life in a phase II studyX Montalban, G Comi, P O'Connor, et al.
Journal of Magnetic Resonance Imaging : JMRI|May 17, 2000
Dynamic susceptibility contrast MR imaging of plaque development in multiple sclerosis: application of an extended blood-brain barrier leakage correctionR Haselhorst, L Kappos, D Bilecen, et al.
Psychopathology|July 27, 2007
Disease variables and depression affecting the process of coping in families with a somatically ill parentB Steck, A Grether, F Amsler, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 31, 2007
Fatigue in multiple sclerosis: relation to depression, physical impairment, personality and action controlI-K Penner, N Bechtel, C Raselli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 30, 2005
A randomized, double-blind, placebo-controlled study of oral hydrolytic enzymes in relapsing multiple sclerosisU Baumhackl, L Kappos, E W Radue, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 27, 2014
Relapses in patients treated with fingolimod after previous exposure to natalizumabG Comi, R Gold, F Dahlke, et al.
Neurology|September 30, 2010
MS quality of life, depression, and fatigue improve after mindfulness training: a randomized trialP Grossman, L Kappos, H Gensicke, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 1, 1997
Intravenous immunoglobulin (IVIG) treatment for patients with primary or secondary progressive multiple sclerosis -- outline of a double-blind randomized, placebo-controlled trialD Poehlau, J Federlein, T Postert, et al.
Pageof 23

Showing results (91-100 of 225) with videos related to

Sort By:
Pageof 23
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 17, 2013
Temporal profile of lymphocyte counts and relationship with infections with fingolimod therapyG Francis, L Kappos, P O'Connor, et al.
Neurology|November 1, 1990
Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individualsM Pette, K Fujita, B Kitze, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 6, 2011
Oral fingolimod (FTY720) in relapsing multiple sclerosis: impact on health-related quality of life in a phase II studyX Montalban, G Comi, P O'Connor, et al.
Journal of Magnetic Resonance Imaging : JMRI|May 17, 2000
Dynamic susceptibility contrast MR imaging of plaque development in multiple sclerosis: application of an extended blood-brain barrier leakage correctionR Haselhorst, L Kappos, D Bilecen, et al.
Psychopathology|July 27, 2007
Disease variables and depression affecting the process of coping in families with a somatically ill parentB Steck, A Grether, F Amsler, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 31, 2007
Fatigue in multiple sclerosis: relation to depression, physical impairment, personality and action controlI-K Penner, N Bechtel, C Raselli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 30, 2005
A randomized, double-blind, placebo-controlled study of oral hydrolytic enzymes in relapsing multiple sclerosisU Baumhackl, L Kappos, E W Radue, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 27, 2014
Relapses in patients treated with fingolimod after previous exposure to natalizumabG Comi, R Gold, F Dahlke, et al.
Neurology|September 30, 2010
MS quality of life, depression, and fatigue improve after mindfulness training: a randomized trialP Grossman, L Kappos, H Gensicke, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 1, 1997
Intravenous immunoglobulin (IVIG) treatment for patients with primary or secondary progressive multiple sclerosis -- outline of a double-blind randomized, placebo-controlled trialD Poehlau, J Federlein, T Postert, et al.
Pageof 23